- $6.45bn
- $4.82bn
- $1.43bn
- 82
- 30
- 81
- 69
Annual income statement for UiPath, fiscal year end - January 31st, USD millions except per share, conversion factor applied.
2021 January 31st | 2022 January 31st | 2023 January 31st | 2024 January 31st | 2025 January 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | PROSPECTUS | 10-K | 10-K | 10-K | 10-K |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Revenue | |||||
| Total Revenue | 608 | 892 | 1,059 | 1,308 | 1,430 |
| Cost of Revenue | |||||
| Gross Profit | 542 | 723 | 879 | 1,112 | 1,186 |
| Selling / General / Administrative Expenses | |||||
| Research And Development | |||||
| Depreciation and Amortization | |||||
| Unusual Expense / Income | |||||
| Other Operating Expenses | |||||
| Total Operating Expenses | 718 | 1,393 | 1,407 | 1,473 | 1,592 |
| Operating Profit | -110 | -501 | -348 | -165 | -163 |
| Total Net Non Operating Interest Income / Expense | |||||
| Other Net Non Operating Costs | |||||
| Net Income Before Taxes | -94.7 | -511 | -318 | -75.8 | -78.1 |
| Provision for Income Taxes | |||||
| Net Income After Taxes | -92.4 | -526 | -328 | -89.9 | -73.7 |
| Net Income Before Extraordinary Items | |||||
| Net Income | -92.4 | -526 | -328 | -89.9 | -73.7 |
| Income Available to Common Shareholders Excluding Extraordinary Items | |||||
| Income Available to Common Shareholders Including Extraordinary Items | |||||
| Diluted Net Income | -92.4 | -526 | -328 | -89.9 | -73.7 |
| Diluted Weighted Average Shares | |||||
| Basic EPS Including Extraordinary Items | |||||
| Diluted EPS Including Extraordinary Items | |||||
| Diluted EPS Excluding Extraordinary Items | |||||
| Normalised Income Before Taxes | |||||
| Normalised Income After Taxes | |||||
| Normalised Income Available to Common Shareholders | |||||
| Diluted Normalised EPS | -0.178 | -1.16 | -0.571 | -0.156 | -0.103 |
| Dividends per Share |